These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24809702)

  • 1. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis.
    Subramani R; Lopez-Valdez R; Arumugam A; Nandy S; Boopalan T; Lakshmanaswamy R
    PLoS One; 2014; 9(5):e97016. PubMed ID: 24809702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma.
    Subramani R; Lopez-Valdez R; Salcido A; Boopalan T; Arumugam A; Nandy S; Lakshmanaswamy R
    Exp Mol Med; 2014 Oct; 46(10):e117. PubMed ID: 25301264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IR-A/IGF-1R-mediated signals promote epithelial-mesenchymal transition of endometrial carcinoma cells by activating PI3K/AKT and ERK pathways.
    Wang C; Su K; Zhang Y; Zhang W; Zhao Q; Chu D; Guo R
    Cancer Biol Ther; 2019; 20(3):295-306. PubMed ID: 30426831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
    Shi H; Fang W; Liu M; Fu D
    Int J Cancer; 2017 Oct; 141(7):1389-1401. PubMed ID: 28608366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancreatic cancer.
    Liu Y; Qin P; Wu R; Du L; Li F
    Hum Cell; 2020 Oct; 33(4):1186-1196. PubMed ID: 32700262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing insulin-like growth factor-1 receptor expression inhibits gastric cancer cell proliferation and invasion.
    Ge J; Chen Z; Huang J; Yuan W; Den Z; Chen Z
    Mol Med Rep; 2015 Jan; 11(1):633-8. PubMed ID: 25339573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 Accelerates the Proliferation and Metastasis of Pancreatic Cancer Cells via the miR-455-5p/IGF-1R Axis.
    Zhang Y; He H; He L; Shi B
    Cancer Biother Radiopharm; 2024 May; 39(4):255-263. PubMed ID: 36595346
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
    Zhu H; Qin H; Li DM; Liu J; Zhao Q
    Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Insulin-Like Growth Factor-1 Receptor (IGF-1R) Reverses the Inhibitory Effect of Let-7g-5p on Migration and Invasion of Nasopharyngeal Carcinoma.
    Zhao Z; Wen J; Peng L; Liu H
    Med Sci Monit; 2019 Aug; 25():5747-5756. PubMed ID: 31374070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration.
    Jaquish DV; Yu PT; Shields DJ; French RP; Maruyama KP; Niessen S; Hoover H; A Cheresh D; Cravatt B; Lowy AM
    Carcinogenesis; 2011 Aug; 32(8):1151-6. PubMed ID: 21565828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
    Matsunaga Y; Adachi Y; Sasaki Y; Koide H; Motoya M; Nosho K; Takagi H; Yamamoto H; Sasaki S; Arimura Y; Tokino T; Carbone DP; Imai K; Shinomura Y
    Mol Carcinog; 2017 Feb; 56(2):515-526. PubMed ID: 27312358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA deleted in lymphocytic leukaemia 1 promotes hepatocellular carcinoma progression by sponging miR-133a to regulate IGF-1R expression.
    Zhang W; Liu S; Liu K; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):5154-5164. PubMed ID: 31207081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of type 1 Insulin-like growth factor receptor expression by small interfering RNA inhibits A549 human lung cancer cell invasion in vitro and metastasis in xenograft nude mice.
    Qian J; Dong A; Kong M; Ma Z; Fan J; Jiang G
    Acta Biochim Biophys Sin (Shanghai); 2007 Feb; 39(2):137-47. PubMed ID: 17277889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginkgoic acid impedes gastric cancer cell proliferation, migration and EMT through inhibiting the SUMOylation of IGF-1R.
    Liu D; Li Z; Yang Z; Ma J; Mai S
    Chem Biol Interact; 2021 Mar; 337():109394. PubMed ID: 33508304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines.
    Zhao H; Desai V; Wang J; Epstein DM; Miglarese M; Buck E
    Mol Cancer Ther; 2012 Feb; 11(2):503-13. PubMed ID: 22161861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MiR-126 inhibits the proliferation and invasion of gastric cancer by downregulation of IGF-1R].
    Wang H; Wang G; Tian WL
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):508-515. PubMed ID: 31357837
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of DACH1 activity by short hairpin RNA represses cell proliferation and tumor invasion in pancreatic cancer.
    Bu XN; Qiu C; Wang C; Jiang Z
    Oncol Rep; 2016 Aug; 36(2):745-54. PubMed ID: 27278537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.